Stock Events

Stock Events

Nymox Pharmaceutical 

$0.100000
1
+$0.08+400% Thursday 14:03

Statistics

Day High
0.02
Day Low
0.02
52W High
0.1999
52W Low
0.0002
Volume
750
Avg. Volume
8,930
Mkt Cap
9.45M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

12AugExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
-0.02
-0.01
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-8.84MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Nymox Pharmaceutical Corporation is a biopharmaceutical firm focused on the research and development of medications for the aging population. Operating internationally, including in Canada, the United States, and Europe, the company's flagship drug candidate is Fexapotide Triflutate (NX-1207). This compound is currently undergoing various clinical trials for conditions such as benign prostatic hyperplasia and low-grade localized prostate cancer, with preclinical investigations also underway for hepatocellular carcinoma. Beyond its drug pipeline, Nymox develops and offers two diagnostic products: NicAlert, which identifies tobacco usage, and TobacAlert, designed to detect exposure to secondhand smoke. The company is also actively engaged in developing treatments for Alzheimer's disease. Nymox Pharmaceutical Corporation was established in 1989 and maintains its headquarters in Nassau, the Bahamas.
Show more...
CEO
Paul Averback
Employees
16
Country
Other
ISIN
BSP733981026

Listings

STU
DE
NYM.STU
MU
DE
NYM.MU
OTC Link
US
NYMXF

0 Comments

Share your thoughts

FAQ

What is Nymox Pharmaceutical stock price today?▼
The current price of NYMXF is $0.10 USD — it has increased by +400% in the past 24 hours. Watch Nymox Pharmaceutical stock price performance more closely on the chart.
What is Nymox Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nymox Pharmaceutical stocks are traded under the ticker NYMXF.
Is Nymox Pharmaceutical stock price growing?▼
NYMXF stock has risen by +400% compared to the previous week, the month change is a +33,233.33% rise, over the last year Nymox Pharmaceutical has showed a +121.73% increase.
What is Nymox Pharmaceutical market cap?▼
Today Nymox Pharmaceutical has the market capitalization of 9.45M
What is Nymox Pharmaceutical revenue for the last year?▼
Nymox Pharmaceutical revenue for the last year amounts to 0 USD.
What is Nymox Pharmaceutical net income for the last year?▼
NYMXF net income for the last year is -8.84M USD.
How many employees does Nymox Pharmaceutical have?▼
As of September 25, 2026, the company has 16 employees.
In which sector is Nymox Pharmaceutical located?▼
Nymox Pharmaceutical operates in the Health & Wellness sector.
When did Nymox Pharmaceutical complete a stock split?▼
Nymox Pharmaceutical has not had any recent stock splits.
Where is Nymox Pharmaceutical headquartered?▼
Nymox Pharmaceutical is headquartered in Nassau, Other.